New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023
GlobeNewswire
MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE^®..
MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE^®..
Preliminary data indicate that improving vitamin D status with oral RAYALDEE results in earlier resolution of respiratory symptoms..
By Sunil J. Wimalawansa*
There is considerable evidence that vitamin D reduces the risk and severity of COVID-19..